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ABSTRACT  
Diabetes is a major public health problem which has been increasing day by day 
throughout the world with an alarming rate. In recent years, several plant extracts 
have been examined for their anti-diabetic properties to identify alternative 
treatment strategies that pose less risk for diabetes. It has been shown that 
different parts of these plants are collected from diverse regions and 
administered in different pharmaceutical preparations. The aim of the present 
review is to provide an overview of the phytochemicals present in S. cumini plants 
and their potent anti-diabetic activity, toxicological and biological effects of these 
plant extracts, their current state, limitation and future prospects in developing 
countries that are not included in the European Pharmacopoeia. In addition, a 
prospective research result of synergistic use of this plant with other plant (Ficus 
racemosa) done presently in our laboratory has been included. Based on the 
available evidence, we highlight the ways in which their therapeutic potential can 
be properly harnessed and provide scientific evidence for the discovery of novel 
leads for herbal drug development. 
INTRODUCTION
Diabetes mellitus (DM) is a most common form of 
diabetes remains a major health care problem 
worldwide both in developing and developed 
countries.[1] It is a metabolic disorder complex in 
nature, resulting in either insulin insufficiency or 
insulin dysfunction with disturbance of 
carbohydrate, fat, and protein metabolism and 
classically characterized by hyperglycemia with 
other clinical presentations such as polyuria, 
polydipsia, polyphagia, fatigue and irritability.[2] 
Worldwide in the years 2012 to 2014, diabetes is 
estimated to have resulted in 1.5 to 4.9 million 
deaths per year and diabetes prevalence in 2019 is 
estimated to be 9.3% (463 million people) making it 
the 8th leading cause of death.[3,4] 
Hyperglycemia can be reversed by a variety of 
measures. Administration of exogenous insulin is 
the treatment for all type-1 diabetic patients and for 
some type-2 patients who do not achieve adequate 
blood glucose control with oral hypoglycemic drugs. 
Insulin therapy has several drawbacks like insulin 
resistance, anorexia, brain atrophy and fatty liver in 
chronic treatment.[5,6] Current drugs used in 
diabetes management can be categorized into three 
groups. Drugs in the first group (sulphonylureas 
such as glibenclamide, the glinides, insulin analogs 
etc.) increase endogenous insulin availability. The 
second group of drugs (thiazolidinediones) 
enhances the sensitivity of insulin. The third group 
comprises the α-glucosidase inhibitors such as 
acarbose, which reduce the digestion of 
polysaccharides and their bioavailability.[7, 8] All the 
existing therapies however have limited efficacy, 
limited tolerability and/or significant mechanism 
based side effects.[9,10] Increasing side effects of 
conventional anti-diabetic medicine are alarming 
the world, so there is an important and immense 
need of doing extensive research work towards the 
anti-diabetic herbal drugs.[11] 
Phyto-medicine is used to treat human illness since 
ancient times, due to their less and non-toxic 
nature.[12] A variety of ingredients present in 
medicinal plants are thought to act on a variety of 
targets by various modes and mechanisms. They 
have potential to impart therapeutic effect in 
complicated disorders like diabetes and its 
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complications.[13] Syzygium cumini is one of them 
and is being claimed in having good effect for 
decreasing the plasma blood sugar level in diabetic 
patients and also can be utilized in conditions/ 
complications related to diabetes and as a 
supportive in diabetes.[14] It has been reported to be 
used in numerous complementary and alternative 
medicine systems of India and before the discovery 
of insulin, was a frontline anti-diabetic medication 
even in Europe.[15] 
The present review is aimed at providing in-depth 
information about the anti-diabetic potential and 
bioactive compounds present in Syzygium cumini, 
based on article published in various scientific 
journals for ensuring the safety, standardization, 
efficacy, quality, availability and preservation of this 
herbal drug by policy-makers, health professionals 
as well as the general public. 
DATA INCORPORATION 
The present review covers the literature available 
from 1956 to 2019. The searched articles were 
screened initially by title and abstract in context to 
the interest of the study. The ethno-botanical 
information was collected from various journals, 
books, theses and electronic search (Google Scholar, 
Pub med, Science Direct, Springer link etc.) for 
publications on S. cumini plants, used in diabetes 
management regarding their effectiveness, 
pharmacological effects, and safety. ‘Diabetes’ and 
‘Plant name – accepted or synonyms’ were used as 
key words for the primary searches. Information 
was also added from the local study (The 
Bangladesh population based diabetes and eye 
study), local agencies (Diabetic Association of 
Bangladesh), Local journals and the research work 
on S. cumini in the universities of Bangladesh. 
Moreover, many published Bangla (Mother tongue 
of Bangladesh and some parts of India) articles 
about these two plants are translated in English and 
included in this review, to make this knowledge 
available to the international community. 
PLANT DESCRIPTION 
Syzygium cumini (Family: Myrtaceae) is a 
polyembryonic species, a tropical fruit tree of great 
economic importance.[16] It is a large evergreen tree 
up to 30 meters height and girth of about 3.6 meters 
with a bole up to 15 meters, with smooth, glossy 
turpentine-smelling leaves. The bark is scaly gray 
and the trunk is forked. There are fragrant white 
flowers in branched clusters at stem tips and 
purplish-black oval edible berries. The berries 
contain only one seed. The taste is generally acidic 
to fairly sweet but astringent. This tree is known to 
have grown in Indian subcontinent and in other 
regions of South Asia such as Nepal, Burma, Sri 
Lanka, Indonesia, Pakistan and Bangladesh from 
ancient time.[15] 
Scientific classification 
Kingdom: Plantae  
Order: Myrtales 
Family: Myrtaceae 
Genus: Syzygium 
Species: Syzygium cumini 
Synonyms: Eugenia jambolana Lam., Myrtus cumini 
Linn., Syzygium jambolana DC.,  
Syzygium jambolanum DC., Eugenia djouant Perr., 
Calyptranthes Jambolana Willd., Eugenia cumini 
(Linn.) Druce. and Eugenia Caryo phyllifolia Lam. 
Common names: Jambolan, Jambul, Black plum, Java 
plum, Portuguese plum, Malabar plum,  
Purple plum, Jamaica and damson plum, Indian 
blackberry, Jamblang, Jamun etc. 
CHEMICAL CONSTITUENTS 
All parts of the Syzygium cumini plants such as 
Bark,[17] Seed,[18,17,19] Leaves,[20,18,19] Fruit,[19] Root,[18] 
Flowers [20, 18] possess diverse phytochemicals. The 
active ingredient in Jaman seed is mycaminose. The 
mechanism of action of mycaminose is similar to 
glibenclamide (a standard drug used for many years 
as anti-diabetic).[21] The other chemical constituents 
responsible for the inhibition of glucose are 
terpenoids, glycosides, saponins, flavanoids, 
phenols etc. Jamun contains an important glycoside 
namely Jambolin which prevents the conversion of 
starch into sugar thereby helps in controlling the 
blood sugar.[11] 
Although almost all parts of the S. cumini has anti-
diabetic activity, seed kernel was used in many 
research experiments. Kumar in their study 
administered Mycaminose at the dose of 50 mg / kg, 
ethyl acetate and methanol extracted compounds of 
Syzygium cumini seeds at the dose of 200 mg/kg 
and 400 mg/kg respectively which was 
administered to streptozotocin-induced diabetic 
rats and found that Mycaminose and ethyl acetate 
and methanol extracts of Syzygium cumini Linn. 
produced significant reduction in blood glucose 
level.[22] Achrekar S concluded in their study that 
the extract of jaman pulp from fruit of Eugenia 
jambolana showed hypoplycemic activity. This 
report is the first evidence of such activity in 
relation to pulp. The effect of pulp was seen in 30 
min, while the seeds of the same fruit required 24 
hour.[23] 
The chemical constituents of different parts are 
enlisted in Fig.1 and phytochemicals which have 
potent anti-diabetic principle are given in Table 1. 
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Figure 1: Phytochemical constituents present in the Syzygium cumini plant 
Table 1: Phytochemicals and their anti-diabetic principles of Syzigium cumini 
Sl No. Phyto 
chemicals 
Chemical structure Anti-diabetic principles with references 
1 Acylated 
flavonol 
glycosides 
 Have potential hypoglycemic effect.[21] 
2 Alkaloids 
 
 Well known for their anti-diabetic activities 
by different mechanisms, Jambosine slows 
down the diastatic conversion of starch into 
sugar.[24] 
3 Anthocyanins  Stimulate insulin secretion from rodent 
pancreatic β-cells in vitro.[25-26] 
4 β-sitosterol  
 
Have potential anti-diabetic activities.[27] 
5 Flavonoids  Regenerate damaged pancreatic β-cells in 
diabetic animals; Inhibitory effect on c’AMP- 
phosphor-reduces blood glucose 
concentration; Have anti-oxidant and free 
radical scavenging properties responsible 
for the anti-diabetic activity.[27-30] 
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6 Glucoside 
(Jamboline 
and ellagic 
acid) 
 Ability to check the conversion of starch into 
sugar in case of excess production of 
glucose; Glycosidases remove sugar 
residues; Jamboline slows down the 
diastatic conversion of starch into sugar.[22, 
24, 31-32] 
7 Myricetin   Lower blood glucose through improved 
glucose utilization in diabetic animals; Has 
potential hypoglycemic effect.[21, 26, 33-34] 
 
8 Polyphenolic 
compounds 
 Have anti-oxidant and free radical 
scavenging properties that might be 
responsible for the anti-diabetic activity.[28] 
9 Quercetin  Promote regeneration of the pancreatic 
islets and increase insulin release; Has 
potential hypoglycemic effect.[21, 26, 35] 
10 Saponins  
 
 Well known for their anti-diabetic activities 
by different mechanisms.[36] 
11 Tannins  Well known for their anti-diabetic activities 
by different mechanisms; Known to possess 
anti-diabetic activity; Have potential 
hypoglycemic effect.[21, 36] 
SUMMARY OF EXPERIMENTAL PROCEDURES 
Scientists used a number of experimental methods to show the anti-diabetic potentials of Syzygium cumini. 
These methods are summarized in Table 2. 
Table 2: Experimental methods followed by various scientists for Syzygium cumini 
Plant 
parts 
Animal model 
used (In vivo) 
Extract type Dose 
(mg/kgbw) 
Duration Route Control 
Seeds Male Wistar 
albino rat  
Ethanolic 250, 500 & 
750  
15, 30 and 
45 days 
Oral Negative control.[37] 
Seeds Albino rat of 
either sex 
Methanolic 500  Single 
dose 
Oral Positive control.[25] 
Seeds Albino rat of 
either sex 
Methanolic 300  7 days Intra 
peritoneal  
Positive & negative 
control.[38] 
Seeds Female albino 
Wistar rat  
Gum Acacia 
suspension 
250, 500 or 
1000  
15 days Oral Positive & negative 
control.[39] 
Seed 
kernel 
Male Sprague 
Dawley rat  
Ethanolic 200  Single 
dose  
Oral Positive & negative 
control.[40] 
Seed 
kernel 
Male albino rat Aqueous 
suspension  
4000 Single 
dose 
Oral Positive & negative 
control.[41] 
Seeds Long‐Evans 
female rat 
Ethanolic extract 
& Seed powder 
1250 21 days Oral Positive & negative 
control.[42] 
Seeds Long Evan’s rat  Methanolic 100 & 300  21 days Oral Positive & negative 
control.[43] 
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Bark Male Wistar 
albino rat 
Aqueous  300 45 days  Oral Positive & negative 
control.[44] 
Pulp Female Wistar 
rat  
Aqueous  100 & 200  15 days Oral Positive & negative 
control.[45] 
Fruit-
pulp 
Albino rabbit Partially purified 
water extract 
25  Single 
dose 
Oral Negative control.[46] 
Leaves Male Wistar 
albino rat 
Aqueous 100 & 200 6 weeks Oral Negative control.[36] 
Seeds Wister albino 
rat of either sex 
Aqueous 400 4 weeks Oral Negative control.[47] 
Seeds Wistar albino 
rat of either sex 
Petroleum ether, 
acetone, methanol 
and water extracts 
100 21 days Oral Positive & negative 
control.[48] 
Seeds Wister albino 
male rat  
Aqueous 250 &500 4 months Oral Positive & negative 
control.[49] 
Seeds Swiss albino 
mice  
Aqueous 150 &250  21 days Oral Negative control.[50] 
N.B: mg: Milligram; gbw: Gram Body Weight; kgbw: Kilogram Body Weight 
Effects of Extracts 
1. Physiological effects (Body weight) 
The effect of different parts of Syzigium cumini on 
body weight of preclinical models (mostly rodents) 
have been investigated by several investigations. 
These preclinical studies are with mixed results as a 
few studies have shown that S. cumini decreased the 
total body weight[42,43] whereas the majority of the 
preclinical reports have indicated that Jamun 
increased the body weight in rodent models of 
diabetes and clinical setting. 
The ethanol extract of seeds has been shown to 
increase (24.18%) body weight in alloxan 
monohydrate induced diabetic rats.[37] The 
administration of methanol extract of seed at 
300mg/kgbw in diabetic rats has also been 
reported significantly increased body weight in 
diabetic rats.[38] Likewise, other studies on aqueous 
seed extract has been found to increase body 
weight in the diabetic rats.[39, 45] The administration 
of aqueous extract of leaves at 100mg/kgbw and 
200mg/kgbw in male wister albino rats has also 
increased the body weight significantly (12.7% and 
16% respectively).[36] 
According to the literature, S. cumini seed ethanolic 
extract @ 500 mg/kgbw showed the best 
improvement in body weight of experimental 
animals.[37] 
2. Hypoglycemic effects  
Excessive hepatic glycogenolysis and gluconeo-
genesis associated with decreased utilization of 
glucose by tissues is the fundamental mechanism 
underlying hyperglycemia in the diabetic state.[51] 
Researchers used a number of doses in order to 
scientifically validate the therapeutic preparation of 
Syzygium cumini plants in the control of 
hyperglycemia (Table 3). Majority of the preclinical 
reports have indicated that different parts of S. 
cumini reduced blood sugar levels in rodents and 
human being. 
The administration of aqueous seed extract of 
Jamun at a dose of 1 g/kg b. wt. in diabetic rats has 
been reported to produce hypoglycaemic effect in 
the blood.[52] The lyophilized powder of aqueous 
seed extract has also been reported to decrease the 
blood glucose level in diabetic mice and rats.[53, 54] 
Similarly, Jamun aqueous seed extract consisting of 
gummy fibres has been highly effective in 
controlling diabetes in alloxan induced diabetes in 
rats. However, in contrast, the aqueous extract 
devoid of gummy fibre did not have any effect on 
blood sugar level.[24] 
The administration of ethanol extract of Jamun 
seeds depleted the blood serum glucose levels in 
the streptozotocin induced diabetic rats in some 
other studies.[25,26] The aqueous and methanol 
extracts of root, stem bark, leaf and seed extracts of 
Jamun has been reported to lower serum glucose 
levels in alloxan-induced diabetes in male Sprague 
Dawley rats in an earlier study.[27] Supplementation 
of Jamun seed powder in human diabetic subject for 
30 days reduced the fasting and post prandial blood 
glucose levels.[28] In a double blinded control clinical 
trial, feeding of 10g of Jamun seed powder up to 90 
days to diabetic patients reduced the fasting blood 
glucose levels by 9%, 18%, and 30% and post 
prandial glucose by 8%, 15%, and 22% after 30, 60, 
and 90 days, respectively.[29] 
Recently, the administration of ethanol extract of 
Jamun seeds and fruits for 60 days reduced serum 
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glucose level in hyperglycaemic/diabetic rats and 
the former was more effective than the later.[30] 
Although Syzygium cumini (seed aqueous extract) 
can reduce blood glucose levels in high fructose diet 
induced diabetic rats, in a dose dependent 
(200mg/kg, 400mg/kg and 800mg/kg) manner, but 
in euglycemic animals it had no effect on the blood 
glucose levels.[31] 
Some other research investigations about 
hypoglycemic effects of S. cumini has been showed 
in a tabular form (Table 3). According to the 
literature, petroleum ether soluble fraction of S. 
cumini seed methanolic extract @ 300 mg/kgbw 
(76.82%) [43] and seed ethanolic extract @ 500 
mg/kgbw (69%) [37] showed the best hypoglycemic 
results (Table 3). 
Table 3: Hypoglycemic changes reported by various scientists on application of Syzygium cumini 
Dose Extract type Decrease Reference  
15 days: (25 mg/100gbw),  
 (50 mg/100gbw), 
 (75mg/100gbw); 
45 days: (250 mg/kgbw)  
 *(500 mg/kgbw) 
 (75mg/100gbw) 
 
 
Ethanolic extract of seed 
24.00% 
46.00% 
50.00% 
50.00% 
69.00% 
58.00% 
 
 
[37] 
 
300 mg/kgbw: Methanolic extract of leaf 26.39% [38] 
250 mg/kgbw: 
500 mg/kgbw: 
1000 mg/kgbw: 
Seed powder suspension in 2% 
gum acacia 
13.00% 
30.00% 
46.00% 
 
[39] 
Single dose: 2h 
Multiple doses: between 9th and 11th day 
 
Seed kernel extract 
14.28% 
28.6-34.2% 
[40] 
 
4000 mg/kgbw Seed kernel extract 12.92% [41] 
1250mg/kgbw  
1250mg/kgbw 
Seed powder 
Ethanolic extract of seed 
29.18% 
38.37% 
[42] 
 
100 mg/kgbw 
*300 mg/kgbw 
Petroleum ether soluble seed  73.19% 
76.82% 
 
 
 
 
[43] 
 100 mg/kgbw 
 300 mg/kgbw 
Carbon tetrachloride soluble 
seed  
11.51% 
18.79% 
 100 mg/kgbw 
 300 mg/kgbw 
Dichloromethane soluble seed  55.03% 
42.82% 
 100 mg/kgbw 
 300 mg/kgbw 
Aqueous soluble seed 20.02% 
14.22% 
100 mg/kgbw 
200 mg/kgbw 
Aqueous extract of pulp 46.30% 
51.23% 
[45] 
300 mg/kgbw Extract of bark 68.56% [44] 
400 mg/kgbw Aqueous extract of seed 37.34% [47] 
100 mg/kgbw 
200 mg/kgbw 
Aqueous extract of leaf 54.28% 
53.81% 
[36] 
 
100 mg/kgbw Methanol extract of seed 56.00% [48] 
N.B: mg: Milligram; gbw: Gram Body Weight; kgbw: Kilogram Body Weight, * Dose for best 
hypoglycemic results 
Biochemical effects 
Liver Glycogen  
The decrease of liver glycogen observed in diabetic 
animal may be due to lack of insulin in diabetic 
state or oxidative stress by diabetes may inactivate 
the glycogen synthetase.[32] In the view of glycogen 
level, there may be three possible way of 
antidiabetogenic action, one possible way may be 
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increased insulin level. Other possible ways of anti-
diabetic action of Syzygium cumini may be by 
preventing the inactivation of the glycogen 
synthetase and by synthesize the glycogen 
synthetase. 
The effect of S. cumini seed powder (250, 500 or 
1000 mg/kg) on diabetic rats showed a difference 
in liver glycogen (50±6.8, 52±7.5 vs normal control 
90 ± 6.6 μg/g of liver tissue, P<0.001).[39] But S. 
cumini seed powder and ethanol extract 
(1.25/kgbw) has no significant effect on liver 
glycogen in streptozotocin (STZ) induced type 2 
diabetic rats after 21 days of consecutive feeding.[42] 
The administration of ethanolic extract of jamun 
seeds 100 mg/kg of body weight increased liver 
glycogen significantly on streptozotocin-induced 
diabetic rats.[33] 
According to the literature, S. cumini leaves aqueous 
extract (100 mg/kgbw) and ethanolic extract of 
seed (500 mg/kgbw) brought the increased levels 
of glycogen (189.40%) to almost normal glycogen in 
liver respectively (Table 4). 
Cholesterol, triglyceride, HDL & LDL 
It is well known that in uncontrolled diabetes 
mellitus, there will be an increase in total 
cholesterol, triglycerides and LDL cholesterol 
associated with decrease in HDL cholesterol.[34] 
Syzygium cumini extracts may inhibit the pathway 
of cholesterol synthesis and increased HDL/LDL 
ratio due to the activation of LDL receptors in 
hepatocytes, which is responsible for taken up LDL 
into the liver and reduce the serum LDL level.  
The seed extract of Jamun showed an alleviation in 
the total serum cholesterol (TC)/high density 
lipoprotein cholesterol (HDL-c) ratio and the 
amount of serum low density lipoprotein 
cholesterol (LDL-c) in alloxan-induced diabetic 
rabbits.[35] Administration of the ethanolic extract of 
different parts of jamun seeds such as whole seed, 
kernel, and seed coat100 mg/kg of body weight 
decreases significantly the levels of cholesterol on 
streptozotocin-induced diabetic rats.[33] But chronic 
feeding of S. cumini powder and ethanol extract did 
not significantly change the total cholesterol and 
triglyceride levels in type 2 diabetic rats. The 
beneficial HDL cholesterol level increased and a 
lowering of LDL cholesterol level was observed.[42] 
Likewise, numerous other studies on different parts 
of S. cumini (aqueous extract of leaf, ethanolic 
extract of seed and fruits) has also been found to 
increase the HDL and decrease the LDL cholesterol 
level.[45,30,36,55] The active principles isolated by 
passing ethanol seed extract fraction of Jamun on 
sephadex gel did decrease triglycerides and total 
cholesterol and raised the HDL cholesterol level in 
the alloxan-induced diabetic rats.[56] 
According to the literature, S. cumini ethanolic 
extract of leaf (125mg/kgbw) and (500 mg/kgbw) 
significantly decrease serum cholesterol (64.17%) 
and triglycerides (68.42%) levels respectively.[57] 
HDL levels were increased (165.08%) after 
treatment with S. cumini leaf aqueous extract 
(200mg/kgbw). The elevated levels of serum LDL 
cholesterol were significantly (61.9%) decreased 
after treatment with aqueous extract of S. cumini 
pulp (200mg/kgbw) (Table 4). 
Table 4: Biochemical changes (Glycogen, Cholesterol, Triglyceride, HDL & LDL) on administration of 
S. Cumini 
Dose 
(mg/kgbw) 
Glycogen Cholesterol Triglyceride HDL LDL Ref 
Normal or 
Increased 
state 
Increase 
(%) 
Decrease 
(%) 
Increase 
(%) 
Decrease 
(%) 
Increase 
(%) 
Decrease 
(%) 
30 days: 
250 & 500  
 
 
 
 
750  
45 days: 
250 & 500* 
750  
Increased 
intensity of 
glycogen  
Almost no 
glycogen  
 
Almost 
normal 
glycogen  
Almost no 
glycogen 
localization 
- 
- 
 
 
 
 
- 
- 
- 
- 
 
 
 
 
- 
- 
- 
- 
 
 
 
 
- 
- 
- 
- 
 
 
 
 
- 
- 
- 
- 
 
 
 
 
- 
- 
- 
- 
 
 
 
 
- 
- 
 
 
 
[37] 
 
500  
1000  
66.67%, 
73.33% 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
[39] 
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100*  189.40% - 46.23 - 41.07 83.73 47.83 [36] 
200**** 169.70% - 48.15 - 42.82 165.08 59.65 
100  - - 19.17 - 28.17 23.86 34.15 [45] 
200***** - - 29.59 - 46.37 44.11 61.89 
125** - - 1h: 64.18 
2h: 39.46 
3h: 59.14 
- 1h: 13.15 
2h: 53.04 
3h: 61.88 
- - [57] 
250 - - 1h: 08.29 
2h: 08.11 
3h: 35.91 
1h: 47.20 
2h: 110.0 
3h: 16.74 
- - - 
500*** - 1h: 06.95 
3h: 03.07 
2h: 05.99 
 
- 1h: 57.99 
2h: 59.51 
3h: 68.43 
- - 
N.B: mg: Milligram; gbw: Gram Body Weight; kgbw: Kilogram Body Weight; h: Hour; HDL: High Density 
Lipoprotein; LDL: Low Density Lipoprotein; Best dose for *glycogen, **Cholesterol, ***Triglyceride, ****HDL 
and *****LDL respectively 
Histological effects (Pancreas and Liver) 
In diabetic animals degenerative changes were seen 
as well as regular arrangement of α and β cells were 
disturbed. But after the treatment of Syzygium 
cumini extract, when blood sugar came down to 
normal level, histology of pancreas and liver have 
showed improvement. 
Aqueous extract of S. cumini bark at a dose of 1g/kg 
of body weight showed the positive staining for 
insulin on cells of the pancreatic duct and 
connective tissue in the pancreas of diabetic rats 
which indicates that the bark of S. cumini stimulates 
development of insulin positive cells from the 
pancreatic duct epithelial cells.[58] After 15 days of 
administration of ethanolic extract of S. cumini seed 
@ 250 mg/kgbw in alloxan-induced diabetic male 
Wistar albino rat, the islets of langerhans did not 
show improvement and were small in size or 
disfigured but after 30 days, β cells achieved 
granulation although some necrosed areas were 
still present within islets.[37] 
According to the literature, S. cumini seed ethanolic 
extract @ 500 mg/kgbw and 750 mg/kgbw showed 
the best improvement in the histology of pancreas 
of experimental animals.[37] 
Ethanolic extract of jamun seed in diabetic rats can 
recover the damaged liver in a dose dependent 
manner. Both the dose (250 mg/kgbw and 500mg/ 
kgbw) can recover the hydropic degeneration of 
liver in a time dependent manner whereas the dose 
@ 750 mg/kgbw did not show any recovery.[37] 
Supplementation of methanolic extract of S. cumini 
seed @ 300 mg/kgbw also restored the 
histopathological changes of liver in alloxan 
induced diabetic rats.[38] 
According to the literature, S. cumini seed ethanolic 
extract @ 500 mg/kgbw showed the best 
improvement in the histology of liver of 
experimental animals.[37] 
Current State, Limitations and Future Prospects 
The diabetes has been increasing throughout the 
globe with an alarming rate due to lifestyle changes 
and it has become a global burden requiring 
attention of the most populated countries, where its 
incidence is ever increasing.[59] The global diabetes 
prevalence in 2019 is estimated to be 9.3% (463 
million people), rising to 10.2% (578 million) by 
2030 and 10.9% (700 million) by 2045.[4] 
People have become more interested in herbal 
medicine because the global burden of treatment 
cost by conventional anti-diabetic medicine is very 
high and the increasing side effects of these 
medicines are alarming in the world.  
A recent study was conducted on induced diabetic 
swiss albino mice at the laboratory of Dept. of 
Anatomy and Histology, Faculty of Veterinary 
Science, Bangladesh Agricultural University, 
Bangladesh. The combined ethanolic extract of S. 
cumini @ 250mg/kgbw and F. racemosa @ 125mg/ 
kgbw was administered orally once daily for 30 
days in comparison to their individual treatments 
(ethanolic extract of S. cumini @ 500mg/kgbw; 
ethanolic extract of F. racemosa @ 250mg/kgbw). 
The fasting blood sugar was measured in controlled 
and treated mice at 14 days interval (at 0, 15 & 30 
d). Results revealed that the lower dose 
combination of ethanolic extracts of S. cumini and F. 
racemosa were effective (p<0.01). Moreover, the S. 
cumini seed extract had shown a better anti-
hyperglycemic activity (36.89%) than that of the F. 
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racemosa fruit extract (31.37%) whereas a lower 
dose combination of these two plant extracts 
showed the best degree of efficacy (47.09% more 
effective).[60] 
From this review study it is clearly demonstrated 
the efficacy of Syzygium cumini in both animal and 
human models of diabetes. Although S. cumini 
reduce the blood glucose level, however, it’s 
mechanism of action yet to provide. Some reported 
activities of Jamun suggested that it acts by 
inhibiting the alpha amylase and alpha glucosidase 
enzyme activity because of having higher content of 
tannins. But for exploring the molecular mechanism 
of action of jamun in various study systems, it is an 
important and immense need of doing extensive 
research work towards the anti-diabetic herbal 
drugs so that can help the present world in a 
descent and nice way of treating these diseases. 
CONCLUSION 
This review provides useful resources to enable a 
thorough assessment of the profile of Syzyigium 
cumini plants and give importance on its use in 
diabetes management. In every section of the 
manuscript, a recommendation has also been 
drawn that would be eventually helpful for the 
researchers in this realm. The review is also aiming 
to draw attention of the relevant researchers to 
expand the use of this plant in ethno-
pharmacotherapy and the development of new 
herbal drugs; as the technology is now extremely 
powerful than before. 
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